2019 Drug Pricing Specialty Pharmacies 
Drug Channels
JULY 21, 2020
pharmacies now participate in the 340B Drug Pricing Program. Below, we update our exclusive analysis of the biggest specialty pharmacies within 340B. As you will see below, these specialty pharmacies have dramatically increased their participation in the 340B program.
Drug Channels
JULY 6, 2020
It’s the 11th edition of our popular and comprehensive examination of the entire drug pricing, reimbursement, and dispensing system. The exhibit below—one of 203 in our new report—provides a first look at the 15 largest pharmacies, ranked by total U.S. prescription dispensing revenues for calendar year 2019.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Channels
JULY 6, 2020
It’s the 11th edition of our popular and comprehensive examination of the entire drug pricing, reimbursement, and dispensing system. The exhibit below—one of 203 in our new report—provides a first look at the 15 largest pharmacies, ranked by total U.S. prescription dispensing revenues for calendar year 2019.
Proxsys Rx
OCTOBER 25, 2024
There are so many ways to optimize your 340B drug program savings and benefits while overcoming manufacturer restrictions. billion in rebates, discounts and fees to insurers, pharmacy benefits managers (PBMs), hospitals, government programs and other healthcare entities. CVS Specialty ( CVS Health ) — $73.3 billion 10.
Putting Patients First Blog
NOVEMBER 14, 2023
NHC Comments on Request for Information: Medicare Transaction Facilitator (MTF) for the Medicare Drug Price Negotiation Program (PDF) November 13, 2023 Benjamin Stidham, Contract Specialist Centers for Medicare & Medicaid Services U.S. Pharmacy benefit managers: transparency, accountability, and impact on patient care.
Putting Patients First Blog
JULY 2, 2024
General Comments The NHC appreciates CMS’ commitment to actively engaging with stakeholders, including patients, consumer advocates, and health experts, in implementing the Medicare Drug Price Negotiation Program (DPNP). Pharmacy benefit managers: transparency, accountability, and impact on patient care. Blendon, R.,
Proxsys Rx
APRIL 19, 2024
Between late 2019 and the end of 2023, ProxsysRx’s 340B Support program went from Zero to more than $500 million in savings generated for the hospitals and health systems we serve. Understand, and master, your 340B specialty pharmacy opportunities. The 340B revenue potential of specialty pharmacy is staggering.
Expert insights. Personalized for you.
52 
Let's personalize your content